Habib Dable Email Address

President and Chief Executive Officer

Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.

PHARMACEUTICAL EXECUTIVE WITH GLOBAL IMPACTIncreasing stakeholder value and meeting the needs of patients around the world. For more than two decades, I have increased profits and expanded market share for organizations in the pharmaceutical industry—from 'big pharma' corporations to small biotech firms. Starting out in sales, I advanced over time to President of Bayer’s largest market. I currently serve as President and CEO of Acceleron Pharma, a publicly traded company. My work as an operations and commercial executive spans geographical regions, drug classes (small molecules, biologics), and therapeutic areas, including cardiovascular disease, hematology, neurology, oncology, ophthalmology, and women’s health. Year after year, my teams have broken new ground by launching mega-brands, penetrating new markets, and outperforming sales expectations in competitive regions. Career Highlights:- Stepped into the role of President and CEO of Acceleron Pharma to build a robust, scalable organization and produce leading-edge products for global patients with serious and rare diseases.- Structured international organizations and revitalized teams, operations, and brand perceptions to navigate industry changes and exceed performance goals for Bayer AG.- Negotiated deals, such as the agreement between Bayer and Orion Corporation; managed partnerships including Genzyme, Orion Corporation, and Regeneron Pharmaceuticals.- Launched billion-dollar products, including Eylea®, Stivarga®, and Xofigo®, and positioned mature brands such as Betaferon®, Kogenate®, and Nexavar® for heightened success. I attribute my success to the determination, expertise, and hard work of my teams. It is a true privilege to work together in the quest to develop patient-centric organizations that deliver life-changing medications globally.